India A. Reddy
No Rating Available
(Learn About Our Rating System)

India A. Reddy, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Mental Health Institute Crisis Care Center

955 West 3300 South
Salt Lake City , UT 84119
Get Directions

Huntsman Mental Health Institute

Adult Inpatient Program
501 Chipeta Way
Salt Lake City , UT 84108
801-581-2121
Get Directions

  • India Reddy, MD, PhD, Assistant Professor (Clinical), is a board-certified psychiatrist with expertise in the treatment of addictive disorders. She completed her medical doctorate and a graduate doctorate in neuroscience at Vanderbilt University, and went on to complete her residency in psychiatry at Vanderbilt University Medical Center. She completed fellowship training in addiction psychiatry through the University of Utah Spencer Fox Eccles School of Medicine before joining the faculty at Vanderbilt in 2023. Dr. Reddy is excited to be back in Utah and currently serves as an attending psychiatrist at the Huntsman Mental Health Institute's Kem and Carolyn Gardner Mental Health Crisis Care Center, treating adults with substance use disorders and other mental health conditions. In addition to her clinical duties, she is involved in research to better understand patterns around the presentation and treatment of mental health conditions using electronic medical record and genetic data. She is also passionate about the education of students, residents, and fellows.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Psychiatry)
    American Board of Psychiatry & Neurology (Sub: Addiction Psychiatry)

  • India Reddy, MD, PhD, Assistant Professor (Clinical), is a board-certified psychiatrist with expertise in the treatment of addictive disorders. She completed her medical doctorate and a graduate doctorate in neuroscience at Vanderbilt University, and went on to complete her residency in psychiatry at Vanderbilt University Medical Center. She completed fellowship training in addiction psychiatry through the University of Utah Spencer Fox Eccles School of Medicine before joining the faculty at Vanderbilt in 2023. Dr. Reddy is excited to be back in Utah and currently serves as an attending psychiatrist at the Huntsman Mental Health Institute's Kem and Carolyn Gardner Mental Health Crisis Care Center, treating adults with substance use disorders and other mental health conditions. In addition to her clinical duties, she is involved in research to better understand patterns around the presentation and treatment of mental health conditions using electronic medical record and genetic data. She is also passionate about the education of students, residents, and fellows.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Assistant Professor (Clinical)
    Academic Divisions Adult Psychiatry
    Board Certification
    American Board of Psychiatry & Neurology (Psychiatry)
    American Board of Psychiatry & Neurology (Sub: Addiction Psychiatry)

    Education history

    Undergraduate Biological Sciences - Cornell University B.A.
    Professional Medical Medical Scientist Training Program - Vanderbilt University School of Medicine M.D., Ph.D.
    Residency Psychiatry- Research Track - Vanderbilt University Medical Center Resident
    Fellowship Addiction Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Kast KA, Le TDV, Stewart LS, Wiese AD, Reddy IA, Smith J, Marcovitz DE, Reese T (2024). Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes. The American journal on addictions, 33(5), 543-550. (Read full publication)
    2. Niarchou M, Sanchez-Roige S, Reddy IA, Reese TJ, Marcovitz D, Davis L (2024). Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records. Translational psychiatry, 14(1), 20. (Read full publication)
    3. Reddy IA, Audet CM, Reese TJ, Peek G, Marcovitz (2024). Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder. Journal of addiction medicine, 18(5), 540-545. (Read full publication)
    4. DiCarlo GE, Mabry SJ, Cao X, McMillan C, Woynaroski TG, Harrison FE, Reddy IA, Matthies HJG, Flynn CR, Wallace MT, Wu H, Galli (2021). Autism-Associated Variant in the SLC6A3 Gene Alters the Oral Microbiome and Metabolism in a Murine Model. Frontiers in psychiatry, 12, 655451. (Read full publication)
    5. Reddy IA, Smith NK, Erreger K, Ghose D, Saunders C, Foster DJ, Turner B, Poe A, Albaugh VL, McGuinness O, Hackett TA, Grueter BA, Abumrad NN, Flynn CR, Galli (2018). Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward. PLoS biology, 16(7), e2006682. (Read full publication)
    6. Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, Fink-Jensen A, Torres GE, Galli (2016). Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational psychiatry, 6(5), e809. (Read full publication)
    7. Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen (2015). The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & behavior, 149, 262-8. (Read full publication)
    8. Reddy IA, Wasserman DH, Ayala JE, Hasty AH, Abumrad NN, Galli (2014). Striatal dopamine homeostasis is altered in mice following Roux-en-Y gastric bypass surgery. ACS chemical neuroscience, 5(10), 943-51. (Read full publication)
    9. Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli (2014). SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Translational psychiatry, 4(10), e464. (Read full publication)
    10. Reddy IA, Stanwood GD, Galli (2014). Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Neurochemistry international, 73, 49-55. (Read full publication)
    11. Gorrindo P, Peltz A, Ladner TR, Reddy I, Miller BM, Miller RF, Fowler M (2014). Medical students as health educators at a student-run free clinic: improving the clinical outcomes of diabetic patients. Academic medicine, 89(4), 625-31. (Read full publication)
    12. Reddy IA, Ballester (2024). Case Report: Dust Remover Inhalant Use Disorder in an Individual in Early Remission from Alcohol Use Disorder Treated with Naltrexone. Substance use & addiction journal, 46(3), 29767342241297436. (Read full publication)
    13. Reddy IA, Han L, Sanchez-Roige S, Niarchou M, Ruderfer DM, Davis L (2025). Identification of Transdiagnostic Childhood Externalizing Pathology Within an Electronic Medical Records Database and Application to the Analysis of Rare Copy Number Variation. American journal of medical genetics. Part B, Neuropsychiatric genetics, e33020. (Read full publication)
    14. Lake AM, Reddy IA, Havranek R, Davis LK, Fox (2025). Clinical Characteristics associated with functional seizures in individuals with psychosis. Schizophrenia research, 281, 209-215. (Read full publication)

    Case Report

    1. Gallagher KC, Geromes AB, Stokes J, Reddy IA, Lewis JS Jr, Baregamian (2018). Rare Undiagnosed Primary Amyloidosis Unmasked During Surgical Treatment of Primary Hyperparathyroidism: A Case Report. Journal of the Endocrine Society, 2(2), 112-116. (Read full publication)